These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 18364659)
21. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Huang YT; Liao CH; Teng LJ; Hsueh PR Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671 [TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]
23. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare. Calfee DP Curr Opin Infect Dis; 2012 Aug; 25(4):385-94. PubMed ID: 22614523 [TBL] [Abstract][Full Text] [Related]
24. Current and emerging serious Gram-positive infections. Menichetti F Clin Microbiol Infect; 2005 May; 11 Suppl 3():22-8. PubMed ID: 15811021 [TBL] [Abstract][Full Text] [Related]
25. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Jones RN Clin Infect Dis; 2006 Jan; 42 Suppl 1():S13-24. PubMed ID: 16323115 [TBL] [Abstract][Full Text] [Related]
29. Daptomycin, a lipopeptide antibiotic in clinical practice. Weis F; Beiras-Fernandez A; Schelling G Curr Opin Investig Drugs; 2008 Aug; 9(8):879-84. PubMed ID: 18666036 [TBL] [Abstract][Full Text] [Related]
30. New Gram-positive antibiotics: better than vancomycin? van Hal SJ; Paterson DL Curr Opin Infect Dis; 2011 Dec; 24(6):515-20. PubMed ID: 21844804 [TBL] [Abstract][Full Text] [Related]
31. Infections caused by Gram-positive bacteria: a review of the global challenge. Woodford N; Livermore DM J Infect; 2009 Sep; 59 Suppl 1():S4-16. PubMed ID: 19766888 [TBL] [Abstract][Full Text] [Related]
32. Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Denys GA; Koch KM; Dowzicky MJ Am J Infect Control; 2007 Oct; 35(8):521-6. PubMed ID: 17936143 [TBL] [Abstract][Full Text] [Related]
33. Susceptibility of clinical methicillin-resistant Staphylococci isolates to new antibiotics. Oksuz L; Gurler N J Infect Dev Ctries; 2013 Nov; 7(11):825-31. PubMed ID: 24240040 [TBL] [Abstract][Full Text] [Related]